CL2022002992A1 - Método para producir productos similares a la leche - Google Patents

Método para producir productos similares a la leche

Info

Publication number
CL2022002992A1
CL2022002992A1 CL2022002992A CL2022002992A CL2022002992A1 CL 2022002992 A1 CL2022002992 A1 CL 2022002992A1 CL 2022002992 A CL2022002992 A CL 2022002992A CL 2022002992 A CL2022002992 A CL 2022002992A CL 2022002992 A1 CL2022002992 A1 CL 2022002992A1
Authority
CL
Chile
Prior art keywords
product
milk
products
producing milk
mammalian
Prior art date
Application number
CL2022002992A
Other languages
English (en)
Inventor
Nabil Bosco Mohamed
Destaillats Frederic
Colombo MOTTAZ Sara
Kraus Marine
Haller Corinne
Mashinchian Omid
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of CL2022002992A1 publication Critical patent/CL2022002992A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A23C9/206—Colostrum; Human milk
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
    • C12N5/0631—Mammary cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436—Fatty acid esters
    • C12P7/6445—Glycerides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/119—Other fibroblast growth factors, e.g. FGF-4, FGF-8, FGF-10
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/12—Hepatocyte growth factor [HGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/315—Prolactin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/33—Insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/00—3D culture

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pediatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Un método para producir un producto similar a la leche de mamífero, por ejemplo un producto similar a la leche humana que comprende generar lactocitos derivados de células madre pluripotentes inducidas de mamíferos (miPSC), por ejemplo células madre pluripotentes inducidas humanas (hiPSC), y expresar el producto similar a la leche de mamífero, por ejemplo el producto similar a la leche humana a partir de lactocitos.
CL2022002992A 2020-04-27 2022-10-27 Método para producir productos similares a la leche CL2022002992A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20171524 2020-04-27
EP21156950 2021-02-12

Publications (1)

Publication Number Publication Date
CL2022002992A1 true CL2022002992A1 (es) 2023-07-07

Family

ID=75660053

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2022002992A CL2022002992A1 (es) 2020-04-27 2022-10-27 Método para producir productos similares a la leche

Country Status (9)

Country Link
US (1) US20230159976A1 (es)
EP (1) EP4142876A2 (es)
CN (1) CN115461119A (es)
AU (1) AU2021263069A1 (es)
BR (1) BR112022021716A2 (es)
CL (1) CL2022002992A1 (es)
IL (1) IL297288A (es)
MX (1) MX2022013442A (es)
WO (1) WO2021219634A2 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3235973A1 (en) * 2021-10-27 2023-05-04 Societe Des Produits Nestle S.A. Method for producing milk like products
AU2022374964A1 (en) * 2021-10-27 2024-04-18 Société des Produits Nestlé S.A. Method for producing milk like products
WO2023073106A1 (en) * 2021-10-27 2023-05-04 Société des Produits Nestlé S.A. Method for producing milk like products
CA3233943A1 (en) * 2021-10-27 2023-05-04 Societe Des Produits Nestle S.A. Method for producing milk like products
WO2023073121A1 (en) * 2021-10-27 2023-05-04 Société des Produits Nestlé S.A. Method for producing milk like products
WO2023110995A1 (en) 2021-12-14 2023-06-22 Inbiose N.V. Production of alpha-1,3-fucosylated compounds
WO2023110994A1 (en) 2021-12-14 2023-06-22 Inbiose N.V. Production of alpha-1,4-fucosylated compounds
WO2023111141A1 (en) 2021-12-15 2023-06-22 Inbiose N.V. Sialyltransferases for the production of sialylated oligosaccharides
WO2023175079A1 (en) 2022-03-16 2023-09-21 Inbiose N.V. Sialyltransferases for the production of sialylated oligosaccharides
WO2023187109A1 (en) 2022-04-01 2023-10-05 Inbiose N.V. Sialyltransferases for the production of sialylated oligosaccharides
WO2024047096A1 (en) 2022-08-30 2024-03-07 Inbiose N.V. Process for purification of an oligosaccharide

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69726738T2 (de) * 1996-08-30 2004-10-21 Nestle Sa Ernährungsrezept für phenylketonurie-patienten
JP2008512398A (ja) * 2004-09-10 2008-04-24 メデラ ホールディング アーゲー 人乳強化剤とその製法
CN101896073B (zh) * 2007-10-09 2013-11-20 酶学技术有限公司 用于治疗胃肠道紊乱和促进肠道发育及成熟的脂质组合物
ES2660416T3 (es) * 2007-11-01 2018-03-22 Enzymotec Ltd. Mezcla de lípidos para la nutrición de bebés
BRPI0913216A2 (pt) 2008-06-23 2016-01-19 Intervet Int Bv uso de um herpesvírus recombinante de perus, e, herpesvírus recombinante de perus.
EP2138186A1 (en) 2008-06-24 2009-12-30 Nestec S.A. Probiotics, secretory IgA and inflammation
CN105120688A (zh) * 2013-04-10 2015-12-02 雀巢产品技术援助有限公司 具有特定比率的低含量MCFAs和相对高含量不饱和脂肪酸的婴儿配方乳，及其在促进婴儿认知功能的健康建立方面的用途
CA2962136A1 (en) * 2014-11-07 2016-05-12 Mjn U.S. Holdings Llc Nutritional compositions containing a prebiotic and lactoferrin and uses thereof
US20170267970A1 (en) * 2016-02-29 2017-09-21 Whitehead Institute For Biomedical Research Three-Dimensional Hydrogels that Support Growth of Physiologically Relevant Tissue and Methods of Use Thereof
US11913022B2 (en) * 2017-01-25 2024-02-27 Cedars-Sinai Medical Center In vitro induction of mammary-like differentiation from human pluripotent stem cells
CN114787343A (zh) * 2019-10-03 2022-07-22 龟树实验室私人有限公司 营养组合物以及用于生产其的方法、试剂盒和细胞组合物

Also Published As

Publication number Publication date
WO2021219634A3 (en) 2021-12-23
US20230159976A1 (en) 2023-05-25
BR112022021716A2 (pt) 2022-12-06
WO2021219634A2 (en) 2021-11-04
IL297288A (en) 2022-12-01
MX2022013442A (es) 2022-11-30
AU2021263069A1 (en) 2022-11-10
CN115461119A (zh) 2022-12-09
EP4142876A2 (en) 2023-03-08

Similar Documents

Publication Publication Date Title
CL2022002992A1 (es) Método para producir productos similares a la leche
CL2021002147A1 (es) Células asesinas naturales (nk) modificadas para inmunoterapia
CL2022002993A1 (es) Método para producir productos similares a la leche
BR112022013569A2 (pt) Construções de célula viva para produção de produto lácteo cultivado e métodos usando as mesmas
BR112017007770A2 (pt) cultura in vitro, população de hipscs, método para modificar um locus-alvo genômico, e, hipsc.
AR080434A1 (es) Metodo para purificar celulas derivadas de celulas madre pluripotenciales
BR112015031233A2 (pt) métodos de produção de derivados de ácidos graxos omega-hidroxilados
BR112013016810A2 (pt) métodos para produção de l-metionina e produtos relacionados
AR082820A1 (es) Diferenciacion de celulas madre embrionarias humanas
CO2021016895A2 (es) Producto alimenticio aviario in vitro
AR102678A1 (es) Producción de ácidos grasos y derivados
MX2022010521A (es) Metodo para producir linfocitos citoliticos naturales a partir de celulas madre pluripotentes.
MX2019007397A (es) Nueva acido 5'-inosinico deshidrogenasa y procedimiento de preparacion de acido 5'-inosinico usando la misma.
CO2021003947A2 (es) Células productoras de insulina
BR112017018704A2 (pt) métodos para produção de células troncos neurais e usos das mesmas
CO2021002704A2 (es) Método de producción de precursores neuronales entéricos
MX2022007571A (es) Metodo de produccion de promotor de crecimiento vegetal, promotor de crecimiento vegetal y metodo de promocion de crecimiento vegetal.
AR116481A1 (es) Biomaterial que comprende células madre derivadas de tejido adiposo y gelatina y método para producir el mismo
BR112021019219A2 (pt) Composição de meio para cultivar clostridium botulinum
BR112023018844A2 (pt) Composições e métodos para geração de células t gama-delta de células-tronco pluripotentes induzidas
BR112022025371A2 (pt) Composição agrícola para quebrar a dormência de gemas de plantas perenes lenhosas, e, métodos para promover brotação em plantas perenes lenhosas, para sincronizar brotação em plantas perenes lenhosas e para promover crescimento em plantas perenes lenhosas
AR119898A1 (es) Métodos para mejorar el tamaño y la calidad de las semillas
AR111981A1 (es) Método para producir cepas mutantes de streptococcus thermophilus
AR118857A1 (es) Microorganismo que produce l-aminoácido y método de producción de l-aminoácido usando el mismo
AR120475A1 (es) Producción de células precursoras hematopoyéticas